Intervention studies showed that punctual exposure to isoflavones slows the rise in prostate-specific antigen (PSA) levels [94], whereas long-term trials were not efficient in avoiding the recurrence of prostate cancer after complete prostatectomy or the progression of advanced-grade neoplasia [95]. This evidence concerns the gene KLK3 and prostate cancer.